Baralgetas injection instructions for use. What helps Baralgetas? Instructions for use. Instructions for use of tablets

Baralgetas is a non-narcotic analgesic agent that also has an antispasmodic effect.

Release form and composition

The drug is available in the form of tablets and solution for injection.

Each tablet of Baralgetas contains:

500 mg metamizole sodium;
5 mg pitofenone hydrochloride;
100 mcg fenpiverinium bromide.

Tablets are sold in 10 pcs. in blisters packed in a cardboard box.

1 ml of Baralgetas solution contains:

500 mg metamizole sodium;
2 mg pitofenone hydrochloride;
20 mcg fenpiverinium bromide.

A solution of 5 ml is sold in dark glass ampoules of 5 pcs. packaged.

Indications for use

According to the data indicated in the instructions for Baralgetas, this analgesic is intended to eliminate mild and moderate pain caused by spasms of smooth muscles. In particular, it is used for:

Renal colic;
Postcholecystectomy syndrome;
biliary colic;
Spasm of the bladder and ureter;
Chronic colpitis;
Dyskinesia of the biliary tract;
intestinal colic;
Diseases of the pelvic organs;
Algodysmenorrhea.

As an aid, Baralgetas is prescribed for pain after diagnostic procedures or surgical interventions.

Also, Baralgetas, according to the instructions, can be used for the short-term treatment of neuralgia, myalgia, sciatica and arthralgia.

Contraindications

According to the annotation to the drug, the use of Baralgetas is contraindicated in:

The presence of hypersensitivity to any component of the drug or to pyrazolone derivatives;
Severe hepatic / renal insufficiency;
severe angina;
Inhibition of bone marrow hematopoiesis;
Deficiency of glucose-6-phosphate dehydrogenase;
Angle-closure glaucoma;
tachyarrhythmias;
Chronic decompensated heart failure;
Intestinal obstruction;
collapse;
Hyperplasia of the prostate;
Megacolone;
Pregnancy and lactation.

In the form of intravenous injections, Baralgetas is not prescribed to children under 1 year old or weighing less than 9 kg, in the form of intramuscular injections - to newborns up to the 3rd month of life or weighing less than 5 kg, in the form of tablets - to children under 5 years old. Regardless of which dosage form of the drug is used, the treatment of a child under the age of 5 years must be carried out under the supervision of a physician.

Prescribe the drug, but with extreme caution in patients with:

Bronchial asthma;
Renal / liver failure;
Hypersensitivity to NSAIDs;
Tendency to arterial hypotension;
A history of acute rhinitis or urticaria provoked by the use of acetylsalicylic acid or other NSAIDs.

Method of application and dosage

Baralgetas tablets are taken 2-4 times a day:

Adults and teenagers from 15 years old - 1-2 pcs.;
Children 12-14 years old - 1-1.5 tablets;
Children 8-11 years old - 0.5-1 tab.;
Children 5-7 years old - 0.5 tab.

The maximum duration of self-administration of Baralgetas is 5 days.

Baralgetas solution can be administered both intravenously and intramuscularly.

In acute severe colic, adults and adolescents from 15 years of age are prescribed 2 ml intravenously, the injection is done within two minutes, if necessary, after 6-8 hours, a second injection is made; intramuscularly - 2-5 ml 2-3 times a day. The maximum allowable daily dose is 10 ml.

Dosages for children:

From 3 to 11 months (or with a weight of 5-8 kg): only in / m at a dose of 0.1-0.2 ml;
1-2 years (9-15 kg): i / m - 0.2-0.3 ml, i / v - 0.1-0.2 ml;
3-4 years (with a weight of 16-23 kg): i / m - 0.3-0.4 ml, i / v - 0.2-0.3 ml;
5-7 years (24-30 kg): i / m - 0.4-0.5 ml, i / v - 0.3-0.4 ml;
8-12 years old (weighing 31-45 kg): i / m - 0.6-0.7 ml, i / v - 0.5-0.6 ml;
12-15 years old: intramuscularly and intravenously - 0.8-1 ml.

The ampoule with the solution should be warmed in the hand before administration.

Side effects

Baralgetas may cause the following adverse reactions:

Urticaria, angioedema, in rare cases - bronchospastic syndrome, toxic epidermal necrolysis, malignant exudative erythema, anaphylactic shock (allergic reactions);
Red coloration of urine, oliguria, impaired renal function, proteinuria, anuria, interstitial nephritis (from the urinary system);
Decreased blood pressure (from the CCC);
Leukopenia, thrombocytopenia, agranulocytosis (from the hematopoietic system);
Dry mouth, accommodation paresis, difficulty urinating, decreased sweating, tachycardia (anticholinergic effects);
Infiltrates at the site of intramuscular injection (local reactions).

special instructions

Parenteral use of the drug is recommended only in cases where oral administration is not possible or absorption from the gastrointestinal tract is impaired. Particular care should be taken when administering more than 2 ml of solution, because. there is a risk of a sharp drop in blood pressure. In / in the drug should be administered slowly, with the patient lying down, under the control of respiratory rate, heart rate and blood pressure.

Until the cause is established, Baralgetas should not be taken to relieve acute abdominal pain.

During treatment with medication, you should refrain from drinking alcoholic beverages.

Long-term use of Baralgetas - more than 7 days - is possible only in agreement with the attending physician and always under the control of the functional state of the liver and peripheral blood picture.

Analogues

Analogues of Baralgetas are the following drugs:

According to the active ingredients: Bioralgin, Bral, Bralangin, Geomag, Maksigan, Plenalgin, Revalgin, Spazgan, Spazmalgon, Spazmalin, Spazmoblok, Spazmogard, Trinalgin;
According to the mechanism of action: Akophil, Analgin, Andipal, Antipyrin, Baralgin M, Benalgin, Quatrox, Quintalgin, Pentabufen, Pentalgin-N, Piralgin, Santoperalgin, Santotitralgin, Sedal-M, Sedalgin-Neo, Tempalgin, Tempanginol, Tetralgin, Sedalgin Plus.

Terms and conditions of storage

Baralgetas is a prescription drug. Its shelf life is 5 years, provided that it is properly stored in a dry place, out of direct sunlight, at temperatures up to 25 ºС.

Found a mistake in the text? Select it and press Ctrl + Enter.

Baralgetas belongs to the category of combined drugs that combine antispasmodic and analgesic effects. The drug is used to relieve pain of various origins.

With myalgia, neuralgia and arthralgia, the medication is used as an emergency remedy. At the stage of postoperative recovery, Baralgetas can be prescribed as an auxiliary drug to alleviate the patient's condition. The action of the analgesic extends to the digestive, genitourinary and other systems of the body. In some pathological processes, the medication is contraindicated for taking. Baralgetas is used in pediatrics, but it also has age restrictions.

You can get acquainted with the reviews of people about this tool at the end of the article.

1. Instruction

This manual contains important information that should be read carefully. This must be done in order to avoid errors in the future.

pharmachologic effect

The effectiveness of Bralgetas in the treatment of pathologies accompanied by pain is due to the combination of certain components in its composition. Each of the active active substances has its own pharmacological properties, which are enhanced by auxiliary elements. The drug acts on the area of inflammation, relaxes the smooth muscle layer and inhibits the synthesis of prostaglandins. Pain relief occurs within thirty minutes.

Pharmacological properties:

m-anticholinergic action;
antipyretic effect;
reduction of symptoms of the inflammatory process;
papaverine-like action on smooth muscles;
relief of pain syndromes of various origins.

Indications

The use of Baralgetas is justified in the weak. as well as moderate painful sensations that are caused by muscle spasms, for example, ureters, biliary and intestinal colic. This remedy can be drunk with biliary dyskinesia, algomenorrhea, chronic colitis, pelvic diseases, and postcholecystectomy syndrome.

The tool can also be used for short-term therapy of arthralgia, myalgia and ischialgia. In addition, very often the remedy is used after surgery to relieve pain.

Mode of application

The required dosage, as well as the duration of treatment, can only be selected by the attending physician. Pills. Adults should take no more than 2 tablets 2 times / day.

For children, the dosage is selected based on the age of the child and his weight:

5-7 years old - the dosage is no more than 1/2 tablet, the maximum dosage per day can be no more than 2 pcs;
8-11 years old - the dosage can be 1/2 tablet, a child can be given no more than 4 pcs per day;
12-14 years - the dose should be no more than 1 tablet at a time. No more than 6 tablets can be given per day.

Solution. The drug in injectable form can be administered to adolescents from 15 years of age, as well as adults at a dosage of 2 ml. Intravenously, the drug must be administered very slowly, i.e. 1 ml for 1 min. If required, the solution is re-introduced after 6 hours. When administered intramuscularly, the drug Baralgetas is administered 2-3 times in 2-5 ml. The maximum permitted dosage per day is 10 ml.

Treatment can last 5 days.

To select the dosage for children, it is important to take into account the age of the baby:

Before the injection, the ampoule needs to be slightly warmed up in the hand.

Release form

In pharmacies, you can find 2 forms of drug release:

Pills;
Solution.

The composition of the tablet/solution includes metamizole sodium, fenpiverinium bromide, and pitofenone hydrochloride.

Interaction

The solution for injection should never be combined with other drugs. Simultaneous reception with alcohol enhances the effect of ethanol. Co-administration with chlorpromazine can provoke the development of hyperthermia.

Contraceptives, antidepressants and allopurine increase the toxicity of Baralgetas. With the simultaneous administration of Baralgetas and cyclosporine, the concentration of the second in human blood decreases several times.

The effectiveness of the tool is increased several times: codeine, propranolol.

2. Side effects

Angioedema, shock, necrolysis, erythema, bronchospasm;
Anuria, discoloration of urine (this does not affect the analyzes in any way), nephritis, proteinuria, and also oliguria;
Thrombocytopenia, agranulocytosis and leukopenia;
A sharp decrease in blood pressure;
Tachycardia, dry mouth, decreased/increased sweating, paresis of accommodation.

Contraindications

This drug should not be taken in conditions such as:

Allergy to the components that make up the product;
Severe form of renal / hepatic insufficiency;
Angina pectoris, glaucoma, intestinal obstruction, hyperplasia, tachyarrhythmia;
Collapse and also megacolon.

In addition, for intravenous administration of the solution, a contraindication is the child's age of the baby (up to 3 months), and for tablets - 5 years.

In addition, the remedy should be administered carefully if there is asthma, the "aspirin" triad.

Pregnancy

During pregnancy, it is better not to use this remedy. This is due to the fact that the drug can have a negative effect on the fetus.

During the period of breastfeeding, the drug should also be abandoned. This is due to the fact that the medicine can have a negative effect on the baby. If it is impossible to refuse the reception, then it is necessary to decide on the termination of natural feeding.

3. Special instructions

Influence on the ability to drive vehicles and control mechanisms

Baralgetas can reduce the speed of psychomotor reactions. During the period of therapy, it is recommended to exclude potentially hazardous activities that involve maintaining concentration. Driving a car should also be avoided.

Pregnancy and lactation

The manufacturer refers pregnancy to the list of contraindications for the use of Baralgetas. It is strictly forbidden to take the drug in the first six weeks of the gestation period. The medication is not compatible with the lactation period. For the duration of therapy, breastfeeding should be discontinued.

Application in childhood

Baralgetas is used in pediatrics, but has age restrictions. In the form of a solution, the drug is prohibited for children under three months old and weighing less than five kilograms. Tablets can only be taken from the age of five.

For disorders of the kidneys

The instruction warns against self-administration of Baralgetas for kidney dysfunctions. In the presence of such pathologies, the drug is used with caution. Severe renal failure is considered an absolute contraindication for the use of an analgesic.

For disorders of the liver

Severe liver failure is a contraindication for the use of Baralgetas. For other liver dysfunctions, the drug is recommended to be used with caution.

Terms of dispensing from pharmacies

The sale of Baralgetas in pharmacies is carried out by prescription.

4. Storage method

The drug should be stored at room temperature in a place where children will not have access. The place must also be protected from moisture and light.

If all conditions are met, then both dosage forms of the drug can be stored for 5 years. After the expiration date has passed, it is forbidden to use the drug further.

5. Price

The exact cost of the drug Baralgetas should be found in pharmacies. Prices can vary significantly depending on the country and region.

Russia

For the drug Baralgetas in Russia, on average, you will have to pay 225 rubles.

Ukraine

On average, you will have to pay 68 hryvnia for a medicine.

Video on the topic: Massage for intestinal colic in newborns and infants

Baralgetas is an effective antispasmodic and analgesic agent, the combination of the components of which leads to the mutual enhancement of their pharmacological properties. Its main action is to relieve spasmolytic phenomena and pain, from which Baralgetas is prescribed for diseases accompanied by spasms and severe pain.

The composition of this drug contains three main substances, the combination of which leads to the elimination of pain, a decrease in body temperature and relaxation of smooth muscles - these are fenpiverinium bromide, pitofenone hydrochloride and metamizole sodium. Pitophenone hydrochloride and fenpiverinium bromide, like papaverine, have a direct myotropic effect on the smooth muscles of the internal organs, causing it to relax. Metamizole is the main active ingredient in this medicine. It helps to reduce the patient's body temperature, eliminate pain and inflammation.

This drug is dispensed in pharmacies only upon presentation of an appropriate prescription from a doctor, so you cannot start taking Baralgetas on your own to eliminate pain and antispasmodic phenomena. And, nevertheless, this medication is very popular among medical professionals who appreciate the wide range of its action.

What are Baralgetas tablets for?

This drug helps with mild to moderate pain of various origins.
Baralgetas is prescribed for spasms of smooth muscles of internal organs that occur with hepatic, intestinal and biliary colic, with biliary dyskinesia, chronic colitis, etc.
This medication is effective for algomenorrhea and other diseases of the pelvic organs.
Baralgetas is often used for the short-term treatment of sciatica, neuralgia, arthralgia and myalgia.
As an adjunct treatment, this remedy is used after various diagnostic or surgical procedures.
In some cases, doctors recommend this drug to normalize elevated body temperature in infectious, inflammatory or colds.

Rules for taking and dosage

The methods of taking this drug depend on the age of the patient, on the nature of his illness, as well as on the individual characteristics of his body.

Adults and teenagers over the age of 15 are recommended to take one or two tablets by mouth several times a day. The maximum daily dosage of the drug is six tablets. The duration of such treatment should not exceed five days. An increase in the duration of treatment or dosage of the drug is possible only under medical supervision.
For children, Baralgetas can only be prescribed by a pediatrician if the risk of taking it is much less than the positive effect that it has. The recommended dosage for children aged 6 to 8 years is half a tablet several times a day. Children from 9 to 12 years old should take three quarters of a tablet 2 to 3 times a day. Those children whose age ranges from 13 to 15 years should take a whole tablet several times a day.

Interaction with other medicines

Taking this medicine with other substances or medicines can cause some side effects, so it is very important that you read the following information before taking it:

alcohol and Baralgetas are incompatible;
the simultaneous use of this drug with other non-narcotic analgesics can cause mutual enhancement of their toxic properties;
Baralgetas, when taken with tricyclic antidepressants, contraceptives, disrupts the metabolism of metamizole in the liver, increasing its toxicity;
tranquilizers and sedatives significantly enhance the analgesic effect of Baralgetas.

Baralgetas is a combined drug that has analgesic, anti-inflammatory and antispasmodic effects. If a doctor recommended it to you, but you don’t know what Baralgetas is taken from and in what situations it is effective to take it, carefully read this article-instruction. In it you will find a lot of interesting information for yourself on the use, combination of this drug with other drugs, etc.

Baralgetas is a drug that has antispasmodic and analgesic effects.

Release form and composition

Baralgetas is available in the form of tablets or solution for intravenous and intramuscular administration. The main active ingredients of the drug: metamizole sodium, fenpiverinium bromide, pitofenone hydrochloride.

Indications for use

As indicated in the instructions, Baralgetas helps relieve pain caused by spasms of smooth muscles. The drug is indicated for use in the following diseases and conditions:

Renal, biliary and intestinal colic;
Spasm of the ureters and bladder;
Biliary dyskinesia;
chronic colitis;
Algodysmenorrhea.

Baralgetas allows you to reduce pain after surgical interventions and diagnostic procedures.

Contraindications

The drug is not prescribed for hypersensitivity to the substances that make up its composition.

The use of Baralgetas is contraindicated in diseases and conditions such as:

Hepatic or renal insufficiency of severe degree;
Deficiency of glucose-6-phosphate dehydrogenase;
Arrhythmia;
Decompensated heart failure;
Angle-closure glaucoma;
Hyperplasia of the prostate;
Intestinal obstruction;
1st trimester and last 6 weeks of pregnancy, lactation.

The introduction of Baralgetas in the form of injections to children under 3 months of age or weighing up to 5 kg is contraindicated. The drug in tablets is not prescribed to patients under the age of 5 years.

Caution requires the use of drugs for bronchial asthma, a tendency to arterial hypotension and hypersensitivity to non-steroidal anti-inflammatory drugs.

Method of application and dosage

According to the attached instructions, Baralgetas in the form of tablets should be taken orally, without chewing, in the following dosage:

Patients over 15 years old - 1-2 tablets 2-3 times a day;
From 12 to 14 years old - 1-1.5 tablets;
From 8 to 11 years old - 0.5-1 tablet;
From 5 to 7 years - 0.5 tablets.

Children under 14 years of age take the drug 4 times a day.

For parenteral administration of Baralgetas, the injection solution should be warmed, holding in the hand, to body temperature. The maximum daily dose for intravenous administration is 6 ml, for intramuscular - 10 ml.

For children from 3 to 12 months, weighing less than 8 kg, the drug is prescribed only intramuscularly.

Side effects

The use of Baralgetas can contribute to the occurrence of such side effects as:

Allergic reactions of varying severity;
Impaired kidney function;
Decreased blood pressure;
Changes in the composition of the blood - thrombocytopenia, leukopenia, agranulocytosis;
Paresis of accommodation.

special instructions

As indicated in the instructions, Baralgetas, when administered intravenously, can cause a sharp decrease in pressure. To reduce this risk, the drug should be administered slowly, the patient should lie down during the procedure.

The medicine can not be used to relieve pain of an unexplained nature in the abdominal cavity.

When using Baralgetas for more than 7 days, it is necessary to control the blood picture and the state of liver function. If agranulocytosis or thrombocytopenia is detected, drug withdrawal is required.

The drug contributes to the staining of urine in red.

Baralgetas has a negative effect on the ability to control mechanisms and vehicles.

Analogues

Analogues of Baralgetas are such drugs as Nebalgan, Spazgan, Spazmalin, Revalgin.

Terms and conditions of storage

Baralgetas should be stored at room temperature. The shelf life of the drug is 5 years.

; 5 mg pitofenone hydrochloride ; 100 mcg fenpiverinium bromide - active ingredients.

Ampoule includes: 2500 mg metamizole sodium ; 2 mg pitofenone hydrochloride ; 20 mcg fenpiverinium bromide - active ingredients.

Release form

The drug Baralgetas is available in the form of tablets of 10 or 100 pieces in one package and in the form of an injection solution in 5 ml ampoules, 5 pieces in one package.

pharmachologic effect

Spasmolytic and analgesic.

Pharmacodynamics and pharmacokinetics

Baralgetas, due to the combined effect of active ingredients that enhance each other's action, is a combined antispasmodic And analgesic drug.

Action pitofenone hydrochloride characterized by direct myotropic (relaxing) effect on smooth muscle . Derivative pyrazolone - metamizole sodium ( ) shows a pronounced analgesic and less pronounced anti-inflammatory And antipyretic action. M-anticholinergic action fenpiverinium bromide complemented by the effect of relaxation of smooth muscles.

Indications for use

Tablets and injections of the drug Baralgetas are prescribed for the manifestation of mild or moderate pain syndrome , due to spasm of smooth muscles internal organs, including: biliary tract, algomenorrhea , bladder and ureter, biliary colic , postcholecystectomy syndrome, intestinal colic , chronic, as well as painful conditions of the pelvic organs.

As a short-term drug for: arthralgia , myalgia , sciatica .

As an adjuvant for pain syndrome triggered by diagnostic and/or surgical procedures.

Contraindications

hypersensitivity to one or the sum of the ingredients of the drug (also to derivatives pyrazolone );
severe pathologies of the liver and / or kidneys;
suppression bone marrow hematopoiesis ;
flaw glucose-6-phosphate dehydrogenase ;
CHF (decompensated);
severe course;
tachyarrhythmias ;
angle-closure glaucoma;
intestinal obstruction;
(with clinical symptoms);
collapse ;
megacolon ;
age up to 5 years for the tablet form and up to 3 months (or with a weight of less than 5 kg) for intravenous injections;
periods lactation And pregnancy .

Take with caution:

at ;
with renal / hepatic insufficiency;
with a predisposition to hypotension ;
with increased sensitivity to NSAIDs ;
with acute or developed due to the intake NSAIDs .

Side effects

Hematopoietic system:

thrombocytopenia ;
leukopenia .

Urinary system:

oliguria ;
weakening of kidney function;
interstitial nephritis ;
red coloration of urine.

The cardiovascular system:

lowering blood pressure .

Allergic manifestations:

hives (among other things, on the mucous membrane of the nasopharynx and conjunctiva);
bronchospastic syndrome;
Lyell's syndrome, as well as Stevens-Johnson's;

dryness in the mouth;
paresis of accommodation ;
decreased sweating;
difficulty urinating ;
with intramuscular injections, infiltrates are possible.

Application instruction of Baralgetas (Way and dosage)

The instruction for Baralgetas involves taking the drug orally (in the form of tablets) and parenterally (in the form of an injection solution).

The maximum dose per day for patients over 15 years of age is 6 tablets; 2-3 times a day, 1-2 tablets of Baralgetas are recommended. Instructions for use advises swallowing the tablets whole (preferably after meals) and drinking water. An increase in the daily dose is possible only on the recommendation of a doctor.

For children, the appointment of Baralgetas is possible only by a doctor and preferably in the minimum daily recommended doses, which should not exceed 2 tablets at the age of 5-7 years; 4 tablets at the age of 8-11 years and 6 tablets at the age of 12-14 years.

With parenteral (in / in, in / m) administration of the drug, it is recommended for patients after 15 years of age, in case of severe and acute colic, intravenous administration of 2 ml of Baralgetas. The introduction is carried out slowly, 1 ml for 60 seconds (it is possible to repeat the injection after 6-8 hours). V / m injections are carried out at a dose of 2-5 ml with a frequency of 2-3 times in 24 hours. It is not recommended to inject more than 10 ml per day. Duration of therapy - no more than 5 days.

The calculation of the pediatric injection dose takes into account the age and weight of the patient:

at the age from 3 to 11 months (5-8 kg), only intramuscular administration at a dose of 0.1-0.2 ml is possible;
at the age from 1 to 2 years (9-15 kg), intravenous injection of 0.1-0.2 ml and intramuscular injection of 0.2-0.3 ml are allowed;
at the age from 3 to 4 years (16-23 kg) it is possible to inject 0.2-0.3 ml in/in and 0.3-0.4 ml in/m;
at the age of 5 to 7 years (24-30 kg) recommend intravenous injection of 0.3-0.4 ml and intramuscular injections of 0.4-0.5 ml;
at the age of 8 to 12 years (31-45 kg), an intravenous dose of 0.5-0.6 ml and an intramuscular dose of 0.6-0.7 ml are indicated;
at the age of 12 to 15 years in / in and / m, the dose can be from 0.8 to 1 ml.

Injection solution, especially before the / in the introduction, it is recommended to warm in the hand.

Overdose

With an overdose of Baralgetas, it can develop, downgrade HELL , confusion, pain in the epigastric region, nausea , liver and kidney disorders, and convulsions .

Overdose therapy is conventional, including gastric lavage, acceptance and symptomatic treatment.

Interaction

Baralgetas injection solution is pharmaceutically incompatible with other drugs.

M-anticholinergic action is enhanced when combined with butyrophenones , H1 blockers (histamine), phenothiazines , , tricyclic antidepressants And quinidine .

Baralgetas increases effects ethanol .

Joint reception with derivatives phenothiazine (Chlorpromazine ) can cause the development hyperthermia pronounced character.

The toxicity of the drug is increased tricyclic antidepressants , And .

Barbiturates , Phenylbutazone and other inducers of liver enzymes reduce the effectiveness of Baralgetas, and anxiolytic And sedatives drugs increase.

When taking Baralgetas, such drugs as colloidal are contraindicated blood substitutes and radiopaque agents.

Joint reception cytostatics And Thiamazole increase the possibility of leukopenia .

The effects of Baralgetas are enhanced when taken , and blockers of H2-histamine receptors.

Terms of sale

Tablets and ampoules of Baralgetas are sold with a prescription.

Storage conditions

All dosage forms of the drug should be stored at temperatures up to 25 ° C.